Concepedia

L. Meysmans

LM

6

Publications

186

Citations

6

H-Index

1986

Active since

Affiliations

Sanofi (Belgium)(Current)

Sanofi (France)

L. Meysmans is an author at Sanofi (Belgium) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

1986–2004

6

Publications

6

Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the β‐adrenoceptor and adenylate cyclase in rat heart

Pierre Chatelain, L. Meysmans, J.R. Mattéazzi et al. · British Journal of Pharmacology · 1995 · 70 citations · Full text

SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.

P. Nokin, M. Clinet, P Beaufort et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 30 citations

SR 33557, a novel calcium-antagonist: interaction with [3H]-(�)-nitrendipine and [3H]-(?)-desmethoxy-verapamil binding sites in cerebral membranes

P. Nokin, M. Clinet, Peter Polster et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2004 · 28 citations

, , +12

Allosteric Modulation of [3H]Nitrendipine Binding to Cardiac and Cerebral Cortex Membranes by Amiodarone

P. Nokin, M. Clinet, S. Swillens et al. · Journal of Cardiovascular Pharmacology · 1986 · 24 citations

Characterization of the slow calcium channel binding sites for [3H]SR 33557 in rat heart sarcolemmal membranes.

Pierre Chatelain, Ph. Beaufort, L. Meysmans et al. · Molecular Pharmacology · 1991 · 18 citations

Rows per page

1–5 of 6